Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
NewAge Inc is a beverages-non-alcoholic business based in the US. NewAge shares (NBEV) are listed on the NASDAQ and all prices are listed in US Dollars. NewAge employs 1,091 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Active traders
Our top pick for
Beginners
Our top pick for
Building a portfolio
| Latest market close | $0.87 |
|---|---|
| 52-week range | $1.00 - $4.55 |
| 50-day moving average | $1.24 |
| 200-day moving average | $1.82 |
| Wall St. target price | $4.38 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.27 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.865 from 2022-01-14
| 1 week (2022-01-10) | -14.36% |
|---|---|
| 1 month (2021-12-17) | -22.07% |
| 3 months (2021-10-15) | -41.16% |
| 6 months (2021-07-16) | -56.31% |
| 1 year (2021-01-15) | -70.88% |
|---|---|
| 2 years (2020-01-17) | -56.09% |
| 3 years (2019-01-17) | 6.64 |
| 5 years (2017-01-17) | 4.0499 |
| Revenue TTM | $439.5 million |
|---|---|
| Gross profit TTM | $176.2 million |
| Return on assets TTM | -3.96% |
| Return on equity TTM | -4.66% |
| Profit margin | -1.62% |
| Book value | $1.51 |
| Market capitalisation | $146.8 million |
TTM: trailing 12 months
We're not expecting NewAge to pay a dividend over the next 12 months.
Over the last 12 months, NewAge's shares have ranged in value from as little as $1 up to $4.55. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NewAge's is 1.0096. This would suggest that NewAge's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
NewAge, Inc. develops, markets, sells, and distributes healthy products in the United States, Japan, China, and internationally. The company operates in two segments, Direct / Social Selling and Direct Store. It provides health and wellness, energy drink, essential oil and anti-aging skincare, cosmetic, beverage, snacks, water and air filtration, and personal care products, as well as weight management, nutritional supplement, nutraceutical, and slenderiize products; diagnostic products, such as DNA testing and diagnostic kits and products; and CBD products. The company offers its products under the Tahitian Noni, LIMU, Zennoa, LIMU Blue Frog, Hiro Natural, TeMana, Lucim, Reviive, Puritii, and MaVie brands. It sells its products directly to customers, as well as through distributors, e-commerce sites, and direct-store-delivery systems. The company was formerly known as New Age Beverages Corporation and changed its name to NewAge, Inc.
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Everything we know about the VinFast IPO, plus information on how to buy in.
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
Everything we know about the Specialty Building Products IPO, plus information on how to buy in.